Verrica Pharmaceuticals Inc. Gain (Loss) on Termination of Lease
Verrica Pharmaceuticals Inc. (VRCA) reported Gain (Loss) on Termination of Lease of -$10.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnTerminationOfLease · last filed 2026-08-06
- Verrica Pharmaceuticals Inc. gain (loss) on termination of lease for the quarter ending 2026-03-31 was -$10.00K.
- Verrica Pharmaceuticals Inc. gain (loss) on termination of lease for the quarter ending 2025-03-31 was -$3.00K.
- Verrica Pharmaceuticals Inc. gain (loss) on termination of lease for the quarter ending 2024-03-31 was $0.00.
- Verrica Pharmaceuticals Inc. gain (loss) on termination of lease for fiscal 2025 was -$1.00K.
- Verrica Pharmaceuticals Inc. gain (loss) on termination of lease for fiscal 2024 was -$19.00K.
- Verrica Pharmaceuticals Inc. gain (loss) on termination of lease for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Verrica Pharmaceuticals Inc. gain (loss) on termination of lease for fiscal 2022 was $6.00K.
| Period end | Gain (Loss) on Termination of Lease 3 month | Gain (Loss) on Termination of Lease 6 month | Gain (Loss) on Termination of Lease 9 month | Gain (Loss) on Termination of Lease 12 month | Gain (Loss) on Termination of Lease 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | -$10.00K 10-Q · filed 2026-08-06 | ||||
| 2026-03-31 | -$10.00K 10-Q · filed 2026-05-12 | ||||
| 2025-12-31 | -$1.00K 10-K · filed 2026-03-11 | ||||
| 2025-09-30 | -$3.00K 10-Q · filed 2025-11-14 | ||||
| 2025-06-30 | -$4.00K 10-Q · filed 2026-08-06 | ||||
| 2025-03-31 | -$3.00K 10-Q · filed 2026-05-12 | ||||
| 2024-12-31 | -$19.00K 10-K · filed 2026-03-11 | ||||
| 2024-09-30 | -$260.00K 10-Q · filed 2025-11-14 | ||||
| 2024-06-30 | $0.00 10-Q · filed 2025-08-12 | ||||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-13 | ||||
| 2023-12-31 | $0.00 10-K · filed 2025-03-11 | ||||
| 2023-09-30 | $0.00 10-Q · filed 2023-11-09 | ||||
| 2022-12-31 | $6.00K 10-K · filed 2024-02-29 | -$6.00K 10-K · filed 2023-03-06 | |||
| 2022-09-30 | $6.00K 10-Q · filed 2023-11-09 | ||||
| 2021-12-31 | $0.00 10-K · filed 2023-03-06 | ||||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |